Filed 2mo ago· Mar 16, 2026
40 days to disclose
Josh Gottheimer
DHouseNew Jersey-05
↑bought
Merck
MRK
$1K-$15K
+0.8% vs S&P 500
Trade dateFeb 4, 2026
Stock
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–100 of 157
Filed 3mo ago· Feb 26, 2026
30 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Gilead Sciences
GILD
$1K-$15K
+0.3% vs S&P 500
Trade dateJan 27, 2026
Filed 10mo ago· Jul 16, 2025
42 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Pfizer
PFE
$1K-$15K
+11.4% vs S&P 500
Trade dateJun 4, 2025
Pfizer, Inc.
Filed 11mo ago· Jun 11, 2025
20 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+6.0% vs S&P 500
Trade dateMay 22, 2025
Filed 11mo ago· Jun 11, 2025
28 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Gilead Sciences
GILD
$1K-$15K
+15.3% vs S&P 500
Trade dateMay 14, 2025
Filed 11mo ago· Jun 11, 2025
29 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+12.6% vs S&P 500
Trade dateMay 13, 2025
Filed 11mo ago· Jun 11, 2025
41 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Eli Lilly
LLY
$1K-$15K
+24.2% vs S&P 500
Trade dateMay 1, 2025
Filed 1.1y ago· May 14, 2025
27 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
AbbVie
ABBV
$1K-$15K
+9.6% vs S&P 500
Trade dateApr 17, 2025
Filed 1.1y ago· May 14, 2025
35 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+7.0% vs S&P 500
Trade dateApr 9, 2025
Filed 1.1y ago· May 14, 2025
35 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
R
RHHBY
$1K-$15K
+7.0% vs S&P 500
Trade dateApr 9, 2025
Filed 1.1y ago· May 14, 2025
35 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+7.0% vs S&P 500
Trade dateApr 9, 2025
Filed 1.1y ago· May 14, 2025
41 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+4.7% vs S&P 500
Trade dateApr 3, 2025
Filed 1.1y ago· May 14, 2025
41 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Intra-Cellular Therapies Inc
ITCI
$1K-$15K
Trade dateApr 3, 2025
Intra-Cellular Therapies
Filed 1.1y ago· May 14, 2025
43 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+2.4% vs S&P 500
Trade dateApr 1, 2025
Filed 1.1y ago· Apr 10, 2025
24 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Intra-Cellular Therapies Inc
ITCI
$1K-$15K
Trade dateMar 17, 2025
Intra-Cellular Therapies
Filed 1.1y ago· Apr 10, 2025
31 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+0.6% vs S&P 500
Trade dateMar 10, 2025
Filed 1.1y ago· Apr 10, 2025
34 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Gilead Sciences
GILD
$1K-$15K
+15.6% vs S&P 500
Trade dateMar 7, 2025
Filed 1.1y ago· Apr 10, 2025
34 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Johnson & Johnson
JNJ
$1K-$15K
−0.5% vs S&P 500
Trade dateMar 7, 2025
Filed 1.2y ago· Mar 6, 2025
15 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+1.4% vs S&P 500
Trade dateFeb 19, 2025
Filed 1.3y ago· Feb 10, 2025
14 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Merck
MRK
$15K-$50K
+0.7% vs S&P 500
Trade dateJan 27, 2025
Stock
Filed 1.3y ago· Feb 10, 2025
17 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Intra-Cellular Therapies Inc
ITCI
$1K-$15K
Trade dateJan 24, 2025
Intra-Cellular Therapies
Filed 1.3y ago· Feb 10, 2025
17 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+54.6% vs S&P 500
Trade dateJan 24, 2025
Filed 1.3y ago· Feb 10, 2025
17 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
+2.9% vs S&P 500
Trade dateJan 24, 2025
Common Stock
Filed 1.3y ago· Feb 10, 2025
20 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+51.9% vs S&P 500
Trade dateJan 21, 2025
Filed 1.3y ago· Feb 10, 2025
25 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+51.3% vs S&P 500
Trade dateJan 16, 2025
Filed 1.3y ago· Feb 10, 2025
33 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+5.8% vs S&P 500
Trade dateJan 8, 2025
Filed 1.4y ago· Jan 14, 2025
27 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+8.1% vs S&P 500
Trade dateDec 18, 2024
Filed 1.4y ago· Jan 14, 2025
29 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+6.6% vs S&P 500
Trade dateDec 16, 2024
Filed 1.4y ago· Jan 14, 2025
32 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+5.3% vs S&P 500
Trade dateDec 13, 2024
Filed 1.4y ago· Jan 14, 2025
33 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+52.9% vs S&P 500
Trade dateDec 12, 2024
Filed 1.4y ago· Jan 14, 2025
33 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+5.3% vs S&P 500
Trade dateDec 12, 2024
Filed 1.4y ago· Jan 14, 2025
34 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+4.5% vs S&P 500
Trade dateDec 11, 2024
Filed 1.4y ago· Jan 14, 2025
35 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+3.1% vs S&P 500
Trade dateDec 10, 2024
Filed 1.4y ago· Jan 14, 2025
36 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+2.6% vs S&P 500
Trade dateDec 9, 2024
Filed 1.5y ago· Dec 5, 2024
6 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
+0.7% vs S&P 500
Trade dateNov 29, 2024
Common Stock
Filed 1.5y ago· Dec 5, 2024
9 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+47.2% vs S&P 500
Trade dateNov 26, 2024
Filed 1.5y ago· Dec 5, 2024
13 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+46.1% vs S&P 500
Trade dateNov 22, 2024
Filed 1.5y ago· Dec 5, 2024
16 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
+5.2% vs S&P 500
Trade dateNov 19, 2024
Common Stock
Filed 1.5y ago· Dec 5, 2024
16 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+5.2% vs S&P 500
Trade dateNov 19, 2024
Filed 1.5y ago· Dec 5, 2024
21 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+2.8% vs S&P 500
Trade dateNov 14, 2024
Filed 1.6y ago· Nov 6, 2024
14 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
−1.3% vs S&P 500
Trade dateOct 23, 2024
Common Stock
Filed 1.6y ago· Nov 6, 2024
21 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
−3.1% vs S&P 500
Trade dateOct 16, 2024
Filed 1.7y ago· Oct 3, 2024
24 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Halozyme Therapeutics
HALO
$1K-$15K
−4.2% vs S&P 500
Trade dateSep 9, 2024
Common Stock
Filed 1.7y ago· Oct 3, 2024
30 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
BioNTech
BNTX
$1K-$15K
−5.3% vs S&P 500
Trade dateSep 3, 2024
Shares
Filed 1.7y ago· Sep 11, 2024
12 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
BioNTech
BNTX
$1K-$15K
−5.5% vs S&P 500
Trade dateAug 30, 2024
Shares
Filed 1.8y ago· Aug 15, 2024
23 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
R
RHHBY
$1K-$15K
+35.2% vs S&P 500
Trade dateJul 23, 2024
Filed 1.8y ago· Aug 15, 2024
45 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+2.5% vs S&P 500
Trade dateJul 1, 2024
Filed 1.8y ago· Aug 15, 2024
45 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
+2.5% vs S&P 500
Trade dateJul 1, 2024
Common Stock
Filed 1.9y ago· Jul 9, 2024
18 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+1.2% vs S&P 500
Trade dateJun 21, 2024
Filed 1.9y ago· Jul 9, 2024
18 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
R
RHHBY
$1K-$15K
+1.2% vs S&P 500
Trade dateJun 21, 2024
Filed 1.9y ago· Jul 9, 2024
18 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Merck
MRK
$1K-$15K
+1.2% vs S&P 500
Trade dateJun 21, 2024
Stock
Filed 1.9y ago· Jul 9, 2024
18 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Intra-Cellular Therapies Inc
ITCI
$1K-$15K
Trade dateJun 21, 2024
Intra-Cellular Therapies
Filed 2.0y ago· Jun 8, 2024
29 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateMay 10, 2024
Common Stock
Filed 2.1y ago· May 15, 2024
30 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
BioNTech
BNTX
$1K-$15K
−1.2% vs S&P 500
Trade dateApr 15, 2024
Shares
Filed 2.2y ago· Apr 7, 2024
24 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
BioNTech
BNTX
$1K-$15K
+1.8% vs S&P 500
Trade dateMar 14, 2024
Shares
Filed 2.2y ago· Mar 7, 2024
28 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+3.0% vs S&P 500
Trade dateFeb 8, 2024
Filed 2.2y ago· Mar 7, 2024
28 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
+3.0% vs S&P 500
Trade dateFeb 8, 2024
Common Stock
Filed 2.2y ago· Mar 7, 2024
35 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Moderna
MRNA
$1K-$15K
+4.4% vs S&P 500
Trade dateFeb 1, 2024
Filed 2.2y ago· Mar 7, 2024
35 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateFeb 1, 2024
Common Stock
Filed 2.3y ago· Feb 15, 2024
17 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Alnylam Pharmaceuticals
ALNY
$1K-$15K
+5.9% vs S&P 500
Trade dateJan 29, 2024
Common Stock
Filed 2.3y ago· Feb 15, 2024
35 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Alnylam Pharmaceuticals
ALNY
$1K-$15K
+47.7% vs S&P 500
Trade dateJan 11, 2024
Common Stock
Filed 2.4y ago· Jan 7, 2024
27 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Alnylam Pharmaceuticals
ALNY
$1K-$15K
+11.7% vs S&P 500
Trade dateDec 11, 2023
Filed 2.4y ago· Jan 7, 2024
31 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
BioNTech
BNTX
$1K-$15K
−21.3% vs S&P 500
Trade dateDec 7, 2023
Shares
Filed 2.4y ago· Jan 7, 2024
32 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
BioNTech
BNTX
$1K-$15K
−20.6% vs S&P 500
Trade dateDec 6, 2023
Shares
Filed 2.4y ago· Jan 7, 2024
33 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
BioNTech
BNTX
$1K-$15K
−18.3% vs S&P 500
Trade dateDec 5, 2023
Shares
Filed 2.5y ago· Dec 8, 2023
22 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Eli Lilly
LLY
$1K-$15K
+63.7% vs S&P 500
Trade dateNov 16, 2023
Filed 2.5y ago· Dec 8, 2023
25 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
+16.9% vs S&P 500
Trade dateNov 13, 2023
Filed 2.5y ago· Dec 8, 2023
25 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateNov 13, 2023
Filed 2.5y ago· Dec 8, 2023
25 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+16.9% vs S&P 500
Trade dateNov 13, 2023
Filed 2.5y ago· Dec 8, 2023
30 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+42.5% vs S&P 500
Trade dateNov 8, 2023
Filed 2.6y ago· Nov 11, 2023
26 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Eli Lilly
LLY
$1K-$15K
+57.9% vs S&P 500
Trade dateOct 16, 2023
Filed 2.6y ago· Nov 11, 2023
26 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Exact Sciences
EXAS
$1K-$15K
Trade dateOct 16, 2023
Filed 2.6y ago· Oct 15, 2023
30 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
CSPC PHARMS GRP U/
CSPCY
$1K-$15K
+12.3% vs S&P 500
Trade dateSep 15, 2023
JT CSPC PHARMS GRP U/ADR
Filed 2.6y ago· Oct 15, 2023
30 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Moderna
MRNA
$1K-$15K
+12.3% vs S&P 500
Trade dateSep 15, 2023
Filed 2.6y ago· Oct 15, 2023
30 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateSep 15, 2023
Filed 2.6y ago· Oct 15, 2023
33 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Eli Lilly
LLY
$1K-$15K
+64.3% vs S&P 500
Trade dateSep 12, 2023
Filed 2.7y ago· Sep 16, 2023
25 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+11.5% vs S&P 500
Trade dateAug 22, 2023
Filed 2.7y ago· Sep 16, 2023
26 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Regeneron Pharmaceuticals
REGN
$1K-$15K
−25.7% vs S&P 500
Trade dateAug 21, 2023
Filed 2.8y ago· Aug 21, 2023
28 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+43.5% vs S&P 500
Trade dateJul 24, 2023
Filed 2.8y ago· Aug 21, 2023
38 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
CSPC PHARMS GRP U/
CSPCY
$1K-$15K
+16.0% vs S&P 500
Trade dateJul 14, 2023
JT CSPC PHARMS GRP U/ADR
Filed 2.8y ago· Aug 21, 2023
38 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Sarepta Therapeutics
SRPT
$1K-$15K
−92.9% vs S&P 500
Trade dateJul 14, 2023
Filed 2.8y ago· Aug 21, 2023
41 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Regeneron Pharmaceuticals
REGN
$1K-$15K
−13.6% vs S&P 500
Trade dateJul 11, 2023
Filed 2.9y ago· Jul 11, 2023
15 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+48.9% vs S&P 500
Trade dateJun 26, 2023
Filed 2.9y ago· Jul 11, 2023
19 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
+12.1% vs S&P 500
Trade dateJun 22, 2023
Filed 2.9y ago· Jul 11, 2023
28 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
CSPC PHARMS GRP U/
CSPCY
$1K-$15K
+27.6% vs S&P 500
Trade dateJun 13, 2023
Pharmaceutical GRP
Filed 2.9y ago· Jul 11, 2023
28 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Sarepta Therapeutics
SRPT
$1K-$15K
+12.9% vs S&P 500
Trade dateJun 13, 2023
Filed 3.0y ago· Jun 11, 2023
26 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
R
RHHBY
$1K-$15K
+13.5% vs S&P 500
Trade dateMay 16, 2023
Depositary Shares
Filed 3.0y ago· Jun 11, 2023
32 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
AbbVie
ABBV
$1K-$15K
+11.8% vs S&P 500
Trade dateMay 10, 2023
Filed 3.0y ago· Jun 11, 2023
33 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Eli Lilly
LLY
$1K-$15K
+134.2% vs S&P 500
Trade dateMay 9, 2023
Filed 3.0y ago· Jun 11, 2023
34 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$1K-$15K
+11.4% vs S&P 500
Trade dateMay 8, 2023
Filed 3.0y ago· Jun 11, 2023
37 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Eli Lilly
LLY
$1K-$15K
+135.5% vs S&P 500
Trade dateMay 5, 2023
Filed 3.0y ago· Jun 11, 2023
41 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateMay 1, 2023
Filed 3.0y ago· May 19, 2023
46 days to disclose · 1 past 45-day windowJosh Gottheimer
DHouseNew Jersey-05
↑bought
Amgen
AMGN
$1K-$15K
+21.9% vs S&P 500
Trade dateApr 3, 2023
Filed 3.1y ago· Apr 20, 2023
24 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Amgen
AMGN
$1K-$15K
+16.2% vs S&P 500
Trade dateMar 27, 2023
Filed 3.1y ago· Apr 20, 2023
27 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
AbbVie
ABBV
$1K-$15K
+16.7% vs S&P 500
Trade dateMar 24, 2023
Filed 3.1y ago· Apr 20, 2023
35 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Eli Lilly
LLY
$15K-$30K
+16.5% vs S&P 500
Trade dateMar 16, 2023
Filed 3.1y ago· Apr 20, 2023
37 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Amgen
AMGN
$1K-$15K
+26.0% vs S&P 500
Trade dateMar 14, 2023
Filed 3.1y ago· Apr 20, 2023
45 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Sarepta Therapeutics
SRPT
$1K-$15K
−101.3% vs S&P 500
Trade dateMar 6, 2023
Filed 3.1y ago· Apr 20, 2023
45 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Moderna
MRNA
$1K-$15K
−81.2% vs S&P 500
Trade dateMar 6, 2023
Filed 3.1y ago· Apr 20, 2023
45 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+25.8% vs S&P 500
Trade dateMar 6, 2023
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Mar 16, 2026 2mo ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Merck MRK Stock | Feb 4, 2026 40 days to disclose | Bad buy·−$323-4.0% +0.8% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 26, 2026 3mo ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Gilead Sciences GILD | Jan 27, 2026 30 days to disclose | Bad buy·−$333-4.2% +0.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 16, 2025 10mo ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Pfizer PFE Pfizer, Inc. | Jun 4, 2025 42 days to disclose | Flat·+0.0% +11.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2025 11mo ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | May 22, 2025 20 days to disclose | Good buy·+$1.6K+19.8% +6.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2025 11mo ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Gilead Sciences GILD | May 14, 2025 28 days to disclose | Flat·+0.0% +15.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2025 11mo ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | May 13, 2025 29 days to disclose | Flat·+0.0% +12.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2025 11mo ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | May 1, 2025 41 days to disclose | Good buy·+$2.6K+32.9% +24.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | AbbVie ABBV | Apr 17, 2025 27 days to disclose | Flat·+0.0% +9.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Apr 9, 2025 35 days to disclose | Flat·+0.0% +7.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | R RHHBY | Apr 9, 2025 35 days to disclose | Flat·+0.0% +7.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Johnson & Johnson JNJ | Apr 9, 2025 35 days to disclose | Flat·+0.0% +7.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | Apr 3, 2025 41 days to disclose | Good buy·+$675+8.4% +4.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Intra-Cellular Therapies ITCI Intra-Cellular Therapies | Apr 3, 2025 41 days to disclose | price pending | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | Apr 1, 2025 43 days to disclose | Good buy·+$480+6.0% +2.4% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 10, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Intra-Cellular Therapies ITCI Intra-Cellular Therapies | Mar 17, 2025 24 days to disclose | price pending | $1K-$15K midpoint $8K |
Apr 10, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Mar 10, 2025 31 days to disclose | Flat·+0.0% +0.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 10, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Gilead Sciences GILD | Mar 7, 2025 34 days to disclose | Good buy·+$1.2K+15.1% +15.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 10, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Johnson & Johnson JNJ | Mar 7, 2025 34 days to disclose | Flat·+0.0% −0.5% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 6, 2025 1.2y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Feb 19, 2025 15 days to disclose | Flat·+0.0% +1.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Merck MRK Stock | Jan 27, 2025 14 days to disclose | Flat·+0.0% +0.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 10, 2025 1.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Intra-Cellular Therapies ITCI Intra-Cellular Therapies | Jan 24, 2025 17 days to disclose | price pending | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Johnson & Johnson JNJ | Jan 24, 2025 17 days to disclose | Good buy·+$4.6K+57.5% +54.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Regeneron Pharmaceuticals REGN Common Stock | Jan 24, 2025 17 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Johnson & Johnson JNJ | Jan 21, 2025 20 days to disclose | Good buy·+$4.5K+56.1% +51.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Johnson & Johnson JNJ | Jan 16, 2025 25 days to disclose | Good buy·+$4.5K+56.5% +51.3% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Jan 8, 2025 33 days to disclose | Flat·+0.0% +5.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 18, 2024 27 days to disclose | Flat·+0.0% +8.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 16, 2024 29 days to disclose | Flat·+0.0% +6.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 13, 2024 32 days to disclose | Flat·+0.0% +5.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Johnson & Johnson JNJ | Dec 12, 2024 33 days to disclose | Good buy·+$4.7K+58.2% +52.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 12, 2024 33 days to disclose | Flat·+0.0% +5.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 11, 2024 34 days to disclose | Flat·+0.0% +4.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 10, 2024 35 days to disclose | Flat·+0.0% +3.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 9, 2024 36 days to disclose | Flat·+0.0% +2.6% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2024 1.5y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Regeneron Pharmaceuticals REGN Common Stock | Nov 29, 2024 6 days to disclose | Flat·+0.0% +0.7% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2024 1.5y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Johnson & Johnson JNJ | Nov 26, 2024 9 days to disclose | Good buy·+$3.9K+48.8% +47.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2024 1.5y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Johnson & Johnson JNJ | Nov 22, 2024 13 days to disclose | Good buy·+$3.9K+49.1% +46.1% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2024 1.5y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Regeneron Pharmaceuticals REGN Common Stock | Nov 19, 2024 16 days to disclose | Flat·+0.0% +5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2024 1.5y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Nov 19, 2024 16 days to disclose | Flat·+0.0% +5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2024 1.5y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Nov 14, 2024 21 days to disclose | Flat·+0.0% +2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 6, 2024 1.6y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Regeneron Pharmaceuticals REGN Common Stock | Oct 23, 2024 14 days to disclose | Flat·+0.0% −1.3% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 6, 2024 1.6y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Oct 16, 2024 21 days to disclose | Flat·+0.0% −3.1% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 3, 2024 1.7y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Halozyme Therapeutics HALO Common Stock | Sep 9, 2024 24 days to disclose | Flat·+0.0% −4.2% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 3, 2024 1.7y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | BioNTech BNTX Shares | Sep 3, 2024 30 days to disclose | Flat·+0.0% −5.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 11, 2024 1.7y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | BioNTech BNTX Shares | Aug 30, 2024 12 days to disclose | Flat·+0.0% −5.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 15, 2024 1.8y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | R RHHBY | Jul 23, 2024 23 days to disclose | Good buy·+$2.8K+35.2% +35.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 15, 2024 1.8y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Jul 1, 2024 45 days to disclose | Flat·+0.0% +2.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 15, 2024 1.8y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Regeneron Pharmaceuticals REGN Common Stock | Jul 1, 2024 45 days to disclose | Flat·+0.0% +2.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 9, 2024 1.9y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Johnson & Johnson JNJ | Jun 21, 2024 18 days to disclose | Flat·+0.0% +1.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 9, 2024 1.9y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | R RHHBY | Jun 21, 2024 18 days to disclose | Flat·+0.0% +1.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 9, 2024 1.9y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Merck MRK Stock | Jun 21, 2024 18 days to disclose | Flat·+0.0% +1.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 9, 2024 1.9y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Intra-Cellular Therapies ITCI Intra-Cellular Therapies | Jun 21, 2024 18 days to disclose | price pending | $1K-$15K midpoint $8K |
Jun 8, 2024 2.0y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Exact Sciences EXAS Common Stock | May 10, 2024 29 days to disclose | price pending | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | BioNTech BNTX Shares | Apr 15, 2024 30 days to disclose | Good buy·+$478+6.0% −1.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2024 2.2y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | BioNTech BNTX Shares | Mar 14, 2024 24 days to disclose | Flat·+0.0% +1.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 7, 2024 2.2y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Feb 8, 2024 28 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 7, 2024 2.2y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Regeneron Pharmaceuticals REGN Common Stock | Feb 8, 2024 28 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 7, 2024 2.2y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Moderna MRNA | Feb 1, 2024 35 days to disclose | Flat·+0.0% +4.4% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 7, 2024 2.2y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Exact Sciences EXAS Common Stock | Feb 1, 2024 35 days to disclose | price pending | $1K-$15K midpoint $8K |
Feb 15, 2024 2.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Alnylam Pharmaceuticals ALNY Common Stock | Jan 29, 2024 17 days to disclose | Flat·+0.0% +5.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 15, 2024 2.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Alnylam Pharmaceuticals ALNY Common Stock | Jan 11, 2024 35 days to disclose | Good buy·+$4.3K+53.2% +47.7% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 7, 2024 2.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Alnylam Pharmaceuticals ALNY | Dec 11, 2023 27 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 7, 2024 2.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | BioNTech BNTX Shares | Dec 7, 2023 31 days to disclose | Bad buy·−$690-8.6% −21.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 7, 2024 2.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | BioNTech BNTX Shares | Dec 6, 2023 32 days to disclose | Bad buy·−$647-8.1% −20.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 7, 2024 2.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | BioNTech BNTX Shares | Dec 5, 2023 33 days to disclose | Bad buy·−$454-5.7% −18.3% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 8, 2023 2.5y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | Nov 16, 2023 22 days to disclose | Good buy·+$6.3K+79.3% +63.7% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 8, 2023 2.5y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Regeneron Pharmaceuticals REGN | Nov 13, 2023 25 days to disclose | Flat·+0.0% +16.9% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 8, 2023 2.5y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Exact Sciences EXAS | Nov 13, 2023 25 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 8, 2023 2.5y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Nov 13, 2023 25 days to disclose | Flat·+0.0% +16.9% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 8, 2023 2.5y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | Nov 8, 2023 30 days to disclose | Good buy·+$4.7K+58.4% +42.5% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 11, 2023 2.6y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | Oct 16, 2023 26 days to disclose | Good buy·+$5.7K+71.2% +57.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 11, 2023 2.6y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Exact Sciences EXAS | Oct 16, 2023 26 days to disclose | price pending | $1K-$15K midpoint $8K |
Oct 15, 2023 2.6y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | CSPC PHARMS GRP U/ CSPCY JT CSPC PHARMS GRP U/ADR | Sep 15, 2023 30 days to disclose | Flat·+0.0% +12.3% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 15, 2023 2.6y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Moderna MRNA | Sep 15, 2023 30 days to disclose | Flat·+0.0% +12.3% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 15, 2023 2.6y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Exact Sciences EXAS | Sep 15, 2023 30 days to disclose | price pending | $1K-$15K midpoint $8K |
Oct 15, 2023 2.6y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | Sep 12, 2023 33 days to disclose | Good buy·+$6.1K+76.1% +64.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 16, 2023 2.7y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Aug 22, 2023 25 days to disclose | Flat·+0.0% +11.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 16, 2023 2.7y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Regeneron Pharmaceuticals REGN | Aug 21, 2023 26 days to disclose | Bad buy·−$1.2K-14.6% −25.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2023 2.8y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | Jul 24, 2023 28 days to disclose | Good buy·+$4.2K+52.7% +43.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2023 2.8y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | CSPC PHARMS GRP U/ CSPCY JT CSPC PHARMS GRP U/ADR | Jul 14, 2023 38 days to disclose | Good buy·+$2.3K+28.8% +16.0% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2023 2.8y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Sarepta Therapeutics SRPT | Jul 14, 2023 38 days to disclose | Bad buy·−$6.4K-80.1% −92.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2023 2.8y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Regeneron Pharmaceuticals REGN | Jul 11, 2023 41 days to disclose | Good buy·+$47+0.6% −13.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 11, 2023 2.9y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | Jun 26, 2023 15 days to disclose | Good buy·+$5K+62.0% +48.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 11, 2023 2.9y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Regeneron Pharmaceuticals REGN | Jun 22, 2023 19 days to disclose | Flat·+0.0% +12.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 11, 2023 2.9y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | CSPC PHARMS GRP U/ CSPCY Pharmaceutical GRP | Jun 13, 2023 28 days to disclose | Missed gain·−$2.9K-35.9% +27.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 11, 2023 2.9y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Sarepta Therapeutics SRPT | Jun 13, 2023 28 days to disclose | Flat·+0.0% +12.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2023 3.0y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | R RHHBY Depositary Shares | May 16, 2023 26 days to disclose | Flat·+0.0% +13.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2023 3.0y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | AbbVie ABBV | May 10, 2023 32 days to disclose | Flat·+0.0% +11.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2023 3.0y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | May 9, 2023 33 days to disclose | Good buy·+$11.7K+146.4% +134.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2023 3.0y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | May 8, 2023 34 days to disclose | Flat·+0.0% +11.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2023 3.0y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | May 5, 2023 37 days to disclose | Good buy·+$11.7K+146.7% +135.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2023 3.0y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Exact Sciences EXAS | May 1, 2023 41 days to disclose | price pending | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Amgen AMGN | Apr 3, 2023 46 days to disclose · 1 past 45-day window | Good buy·+$2.8K+35.3% +21.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 20, 2023 3.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Amgen AMGN | Mar 27, 2023 24 days to disclose | Flat·+0.0% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 20, 2023 3.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | AbbVie ABBV | Mar 24, 2023 27 days to disclose | Flat·+0.0% +16.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 20, 2023 3.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Mar 16, 2023 35 days to disclose | Flat·+0.0% +16.5% vs S&P 500 | $15K-$30K midpoint $22.5K |
Apr 20, 2023 3.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Amgen AMGN | Mar 14, 2023 37 days to disclose | Good buy·+$3.5K+43.4% +26.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 20, 2023 3.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Sarepta Therapeutics SRPT | Mar 6, 2023 45 days to disclose | Bad buy·−$6.9K-86.3% −101.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 20, 2023 3.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Moderna MRNA | Mar 6, 2023 45 days to disclose | Bad buy·−$5.3K-66.1% −81.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 20, 2023 3.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | Mar 6, 2023 45 days to disclose | Good buy·+$3.3K+40.8% +25.8% vs S&P 500 | $1K-$15K midpoint $8K |